KMC Speciality Hospitals Posts Stellar Q3 Earnings With 82% PAT Surge

HEALTHCAREBIOTECH
Whalesbook Logo
AuthorSatyam Jha|Published at:
KMC Speciality Hospitals Posts Stellar Q3 Earnings With 82% PAT Surge
Overview

KMC Speciality Hospitals India Limited reported robust Q3 FY26 results, with revenue climbing 33.74% YoY to ₹82.06 Cr and PAT soaring 82.74% to ₹13.73 Cr. PAT margins expanded significantly to 16.50% from 12.01% YoY. Nine-month performance also showed strong double-digit growth across revenue and profit.

📉 The Financial Deep Dive

KMC Speciality Hospitals (India) Limited has posted a strong financial performance for the third quarter and nine months ended December 31, 2025. The standalone un-audited results, reviewed by Deloitte Haskins & Sells, show significant year-on-year improvements.

The Numbers:

  • Revenue for Q3 FY26 surged by 33.74% YoY to ₹8,206.03 Lakhs (₹82.06 Cr), up from ₹6,136.41 Lakhs (₹61.36 Cr) in Q3 FY25.
  • Profit After Tax (PAT) witnessed an impressive 82.74% jump YoY to ₹1,372.78 Lakhs (₹13.73 Cr), compared to ₹751.38 Lakhs (₹7.51 Cr) in the prior-year period.
  • Profit Before Tax (PBT) also rose substantially by 83.86% YoY.
  • Basic and Diluted EPS for the quarter increased to ₹0.84, up from ₹0.46 YoY.

Sequentially, revenue grew 9.56% QoQ to ₹82.06 Cr, and PAT saw a healthy 26.66% increase QoQ to ₹13.73 Cr, with EPS rising from ₹0.66 to ₹0.84.

For the nine months ended December 31, 2025, revenue grew 30.98% YoY to ₹22,351.51 Lakhs (₹223.52 Cr), while PAT more than doubled, increasing by 89.83% YoY to ₹3,210.10 Lakhs (₹32.10 Cr).

The Quality:
The company demonstrated considerable improvement in profitability. PAT margin expanded from 12.01% in Q3 FY25 to 16.50% in Q3 FY26, indicating enhanced operational efficiency or better pricing power. The independent auditor's limited review report found no material misstatements, providing a clean bill of health for the reported financials.

The Grill:
The company's announcement did not include any forward-looking guidance or outlook. This absence leaves investors without specific management commentary on future growth drivers, demand trends, or strategic plans for the upcoming quarters.

🚩 Risks & Outlook
Given the lack of forward-looking statements from the management, specific risks and outlook are difficult to ascertain from the provided text. However, the strong performance suggests positive momentum in the healthcare sector, particularly for KMC Speciality Hospitals. Investors will likely watch for sustained growth, continued margin expansion, and any future announcements regarding capacity expansion or new service offerings.

Disclaimer:This content is for educational and informational purposes only and does not constitute investment, financial, or trading advice, nor a recommendation to buy or sell any securities. Readers should consult a SEBI-registered advisor before making investment decisions, as markets involve risk and past performance does not guarantee future results. The publisher and authors accept no liability for any losses. Some content may be AI-generated and may contain errors; accuracy and completeness are not guaranteed. Views expressed do not reflect the publication’s editorial stance.